Chronic myeloid leukemia treated with busulfan. Clinical characteristics, prognostic factors, effect of treatment and survival in 82 cases
Larrain, C.; Cruz, A.; Codoceo, V.
Revista Medica de Chile 112(9): 898-911
1984
ISSN/ISBN: 0034-9887 PMID: 6598227 Document Number: 228355
Document emailed within 1 workday
Related Documents
Jonte, F.; Fernández-Fuertes, F.; Cecchini, C.; Luño, E.; Ordóñez, A.; Fernández, C.; Suárez, P.; Lausín, A.; Fernández, J. 1992: Cause of death, survival, and prognostic factors in a series of 98 patients with chronic myeloid leukemia Sangre 37(5): 351-354Cervantes, F.; Rozman, C.; Nomdedeu, B.; Blade, J.; Montserrat, E. 1986: Chronic myeloid leukemia: comparison of monotherapy with busulfan with busulfan and vincristine and 6-mercaptopurine cycles Revista Clinica Espanola 178(1): 4-7
Cervantes, F.; Hernández-Boluda, J-Carlos.; Steegmann, J-Luis.; Conde, E.; Alvarez-Larrán, A.; López-Jiménez, J.; Osorio, S.; Villalón, Lía.; Camós, M.; García-Conde, J.; Odriozola, Jús. 2003: Imatinib mesylate therapy of chronic phase chronic myeloid leukemia resistant or intolerant to interferon: results and prognostic factors for response and progression-free survival in 150 patients Haematologica 88(10): 1117-1122
Takami, A.; Chuhjo, T.; Nakao, S. 2002: Relapse of chronic myeloid leukemia (CML) in lymphoid crisis after allogeneic bone marrow transplantation for CML in chronic phase with busulfan plus cyclophosphamide regimen Haematologica 87(6): 659-661
Ashariati, A.; Ugroseno, S. 2013: Profile of BCR-ABL transcript levels based on Sokal prognostic score in chronic myeloid leukemia patients treated with imatinib Acta Medica Indonesiana 45(2): 107-113
Boma, P.O.; Durosinmi, M.A.; Adediran, I.A.; Akinola, N.O.; Salawu, L. 2006: Clinical and prognostic features of Nigerians with chronic myeloid leukemia Nigerian Postgraduate Medical Journal 13(1): 47-52
Jootar, S.; Ungkanont, A.; Chuncharunee, S.; Atichartakarn, V. 1996: Multivariate analysis of prognostic factors in Philadelphia chromosome positive chronic myeloid leukemia: an update of the first series in Thailand Asian Pacific Journal of Allergy and Immunology 14(1): 25-30
Armenta, D.; Espallargas, C.; Paz, A.; Rodríguez Martorel, J.; Ladines, R.; Alvarez, C.; Román, J.; Andrés, P. 1996: Complete cytogenetic remission of chronic myeloid leukemia with low-dose interferon alfa-2b and monthly high-dose busulfan Sangre 41(6): 465-467
Gao, J.S.; Zhang, G.R.; Zhu, B.X.; Xu, M.Y.; Xue, Y.Q.; Shao, J.Z.; He, Z.X.; Hu, Z.D. 1987: Clinical classification of 109 chronic myeloid leukemia cases and its correlation with Ph chromosomes Chinese Medical Journal 100(4): 333-334
Petti, M.C.; Aloe Spiriti, M.A.; Latagliata, R.; Spadea, A.; Tirindelli, M.C.; Vegna, M.L. 1989: Acute myeloid leukemia: prognostic factors Haematologica 74(5 Suppl): 380-391
del Vecchio, T.; Carlesimo, F.; Cortese, M. 1976: Splenectomy in myeloid chronic leukemia in the pre-blastic phase. Presentation of 3 clinical cases and analysis of literature Annali Italiani di Chirurgia 48(1): 111-117
Tomás, J.F.; Peñarrubia, M.J.; García, J.A.; Figuera, A.; Gómez-García de Soria, V.; Steegmann, J.L.; Arranz, R.; Cámara, R.; Gabriel, R.; Vázquez, L. 1995: Allogeneic bone marrow transplantation in chronic myeloid leukemia. the clinical results and risk factors in 70 patients Medicina Clinica 105(16): 605-611
Siddiqui, T.; Durkin, W.J.; Conley, N.S.; Doughney, K.B.; Favis, G.R.; Weiss, R.; Smith, A.E. 1994: Comparison of survival. Chemotherapeutically treated and untreated older patient with acute myeloid leukemia Journal of the Florida Medical Association 81(7): 475-477
Rizzo, S.C.; Balduini, C.L.; Invernizzi, R.; Ricevuti, G.; Fontana, G.; Ascari, E. 1980: Prognostic factors and treatment response in acute lymphoblastic leukemia of children and adults treated with a non aggressive combination chemotherapy Haematologica 65(1): 70-81
Sennana Sendi, H.; Elghezal, H.; Temmi, H.; Gribaa, M.; Laatiri, A.èn.; Ben Abid, H.él.; Ben Abdeladhime, A.; Elloumi, M.; Hafsia, A.; Saad, A. 2002: Prognostic impact of karyotype in de novo acute myeloid leukemia: study of 139 cases La Tunisie Medicale 80(9): 531-535
Bergholm, U.; Adami, H.O.; Bergström, R.; Bäckdahl, M.; Akerström, G. 1990: Long-term survival in sporadic and familial medullary thyroid carcinoma with special reference to clinical characteristics as prognostic factors. The Swedish MTC Study Group Acta Chirurgica Scandinavica 156(1): 37-46
Tsuji-Takayama, K.; Kamiya, T.; Nakamura, S.; Matsuo, Y.; Adachi, T.; Tsubota, T.; Imanishi, J.; Minowada, J. 1994: Establishment of multiple leukemia cell lines with diverse myeloid and/or megakaryoblastoid characteristics from a single Ph1 positive chronic myelogenous leukemia blood sample Human Cell 7(3): 167-171
Alimena, G.; Montuoro, A.; Gastaldi, R.; Lombardi, A.; Dallapiccola, B. 1979: Biological significance and prognostic implications of the involvement of the sex chromosomes in the evolution of chronic myeloid leukemia (CML) Pathologica 71(1013): 392-393
Meloni, G.; Russo, D.; Baccarani, M.; Testoni, N.; Martinelli, G.; Fanin, R.; Zuffa, E.; Rosti, G.; Alimena, G.; Saglio, G.; Mandelli, F.; Tura, S. 1999: A prospective study of alpha-interferon and autologous bone marrow transplantation in chronic myeloid leukemia. the Italian Co-operative Study Group on Chronic Myeloid Leukemia Haematologica 84(8): 707-715
Rujkijyanont, P.; Kaewinsang, S.; Monsereenusorn, C.; Traivaree, C. 2014: Pediatric acute leukemia: the effect of prognostic factors on clinical outcomes at Phramongkutklao Hospital, Bangkok, Thailand Journal of the Medical Association of Thailand 97(Suppl 2): S188-S195